anti-IMP3, U3 small nucleolar ribonucleoprotein, homolog antibody product blog
Tags: Antibody; Polyclonal Antibody; IMP3, U3 small nucleolar ribonucleoprotein, homolog; anti-IMP3, U3 small nucleolar ribonucleoprotein, homolog antibody;
The IMP3, U3 small nucleolar ribonucleoprotein, homolog n/a (Catalog #MBS713855) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Rabbit anti-human IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast) polyclonal Antibody reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s IMP3, U3 small nucleolar ribonucleoprotein, homolog can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB). Researchers should empirically determine the suitability of the IMP3, U3 small nucleolar ribonucleoprotein, homolog n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Human IMP3. Storage Buffer: PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20 degree C, Avoid freeze / thaw cycles.
Santa Cruz Alternative: Potential replacement for Santa Cruz Biotechnology antibody catalog# sc-104328. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing IMP3, U3 small nucleolar ribonucleoprotein, homolog are readily searchable from our website. Different antibodies against the same target such as IMP3, U3 small nucleolar ribonucleoprotein, homolog may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.